Literature DB >> 1428120

Molecular mechanism of methotrexate action in inflammation.

B N Cronstein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1428120     DOI： 10.1007/bf00918968

Source DB:  PubMed          Journal:  Inflammation        ISSN： 0360-3997            Impact factor:   4.092


× No keyword cloud information.
  74 in total

1.  The influence of methotrexate and thymidine on the human natural killer cell function in vitro.

Authors:  D S Matheson; B Green; D I Hoar
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

2.  Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.

Authors:  B N Cronstein; M A Eberle; H E Gruber; R I Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization.

Authors:  B N Cronstein; S B Kramer; E D Rosenstein; H M Korchak; G Weissmann; R Hirschhorn
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

4.  Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial.

Authors:  M E Weinblatt; H Kaplan; B F Germain; R C Merriman; S D Solomon; B Wall; L Anderson; S Block; R Irby; F Wolfe
Journal:  Arthritis Rheum       Date:  1990-03

5.  Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.

Authors:  H J Williams; R F Willkens; C O Samuelson; G S Alarcón; M Guttadauria; C Yarboro; R P Polisson; S R Weiner; M E Luggen; L M Billingsley
Journal:  Arthritis Rheum       Date:  1985-07

6.  The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.

Authors:  J M Kremer; J K Lee
Journal:  Arthritis Rheum       Date:  1986-07

7.  Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study.

Authors:  M E Weinblatt; H Kaplan; B F Germain; R C Merriman; S D Solomon; B Wall; L Anderson; S Block; R Small; F Wolfe
Journal:  J Rheumatol       Date:  1991-03       Impact factor: 4.666

8.  Inhibition of macrophage phagocytosis by methylation inhibitors. Lack of correlation of protein carboxymethylation and phospholipid methylation with phagocytosis.

Authors:  S J Sung; S C Silverstein
Journal:  J Biol Chem       Date:  1985-01-10       Impact factor: 5.157

9.  Long-term methotrexate treatment in corticosteroid-dependent asthma.

Authors:  M F Mullarkey; J K Lammert; B A Blumenstein
Journal:  Ann Intern Med       Date:  1990-04-15       Impact factor: 25.391

10.  Efficacy of low-dose methotrexate in rheumatoid arthritis.

Authors:  M E Weinblatt; J S Coblyn; D A Fox; P A Fraser; D E Holdsworth; D N Glass; D E Trentham
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245
View more
  18 in total

Review 1.  Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?

Authors:  Heinrike Schmeling; Gerd Horneff; Susanne M Benseler; Marvin J Fritzler
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

2.  Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes.

Authors:  Charles F Spurlock; Henry M Gass; Carson J Bryant; Benjamin C Wells; Nancy J Olsen; Thomas M Aune
Journal:  Rheumatology (Oxford)       Date:  2014-08-12       Impact factor: 7.580

3.  Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?

Authors:  L D Fairbanks; K Rückemann; Y Qiu; C M Hawrylowicz; D F Richards; R Swaminathan; B Kirschbaum; H A Simmonds
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

4.  Slow recovery of follicular B cells and marginal zone B cells after chemotherapy: implications for humoral immunity.

Authors:  A Zandvoort; M E Lodewijk; P A Klok; P M Dammers; F G Kroese; W Timens
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

5.  Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis.

Authors:  E Thomas; J L Leroux; F Blotman; C Chavis
Journal:  Inflamm Res       Date:  1995-03       Impact factor: 4.575

6.  Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells.

Authors:  C H Nielsen; L Albertsen; K Bendtzen; B Baslund
Journal:  Clin Exp Immunol       Date:  2007-02-07       Impact factor: 4.330

Review 7.  Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives?

Authors:  Alexandros Drosos
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases.

Authors:  J Spychala; N S Datta; K Takabayashi; M Datta; I H Fox; T Gribbin; B S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

Review 9.  Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.

Authors:  Alejandro Díaz-Borjón
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

10.  A lentivirus-mediated genetic screen identifies dihydrofolate reductase (DHFR) as a modulator of beta-catenin/GSK3 signaling.

Authors:  Richard A Klinghoffer; Jason Frazier; James Annis; Jason D Berndt; Brian S Roberts; William T Arthur; Raul Lacson; Xiaohua Douglas Zhang; Marc Ferrer; Randall T Moon; Michele A Cleary
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.